Drug doses are established in phase I studies, but infusion length or administration frequency are commonly determined empirically based on available preclinical data.
Patients were to be treated at the dose of irinotecan established in Phase I with 400 mg of oral sorafenib b.d.
The safety profile of Treg cells has been established in phase I clinical trials [ 11, 12] demonstrating that Treg cells are a suitable candidate for therapeutic purposes.
This assumption was based on the high response rates of WHO grade III anaplastic oligodendroglioma, as compared to grade III anaplastic astrocytoma, established in phase II trials in the 1990s [ 2].
Bevacizumab pharmacokinetics is well established in phase-I, -II, and -III studies as a single agent or in combination with chemotherapy for both single- and multiple-dose administration with both rich and sparse bevacizumab serum concentration data (14– 14).
Any reported adverse events are consistent with the adverse-event profile of gefitinib established in Phase II trials in patients with advanced NSCLC (Fukuoka et al, 2003; Kris et al, 2003).
The efficacy of docetaxel as a single agent (Nabholtz et al, 1999; Sjostrom et al, 1999; Jones et al, 2005) or in combination with cytotoxic agents (O'Shaughnessy et al, 2002; Chan et al, 2005) has been established in phase III trials in this setting.
Although there are no clearly identified off-target adverse effects to date, the profile established in Phase III will need to be confirmed and refined with further experience in larger numbers of patients, as is the case for all diabetes medications.
Stick to the ACE that you established in Phase 3 for limiting your daily carbs.
The integrated methodology was designed for the pulp and paper industry and was established in several phases.
